Related Experiment Videos
Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features
K Pham1, T Milovanovic, R J Barr
1Division of Hematology/Oncology and Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92868, USA.
Molecular Pathology : MP
|September 30, 2003
Summary
Wnt ligand expression in melanoma varies with cell type. Benign moles show consistent Wnt expression, while malignant melanomas display altered patterns, potentially aiding molecular classification.
Area of Science:
- Molecular biology
- Oncology
- Dermatopathology
Background:
- Secreted Wnt ligands are crucial for cell signaling, influencing growth and differentiation.
- Aberrant Wnt pathway activity is implicated in various cancers, including malignant melanoma.
Purpose of the Study:
- To investigate the expression patterns of specific Wnt ligands in benign nevi and malignant melanoma.
- To correlate Wnt ligand expression with distinct histopathological features of melanoma.
Main Methods:
- In situ antisense RNA hybridization was used to analyze Wnt2, Wnt5a, Wnt5b, Wnt7b, and Wnt10b expression in tissue sections.
- Immunoperoxidase staining assessed frizzled (Fz) receptor expression.
Main Results:
- Benign nevi consistently expressed Wnt2, Wnt5a, Wnt7b, and Wnt10b.
- Melanomas with small, uniform cells mirrored benign nevi's Wnt expression.
- Melanomas with large, pleomorphic cells showed reduced Wnt2 and Wnt5a expression, with variable Wnt7b and retained Wnt10b. Frizzled receptor expression was low across all samples.
Conclusions:
- Wnt ligand expression profiles in malignant melanoma correlate with histopathological characteristics.
- These findings may facilitate a molecular classification system for melanoma.